Contributed by:

PharmaVOICE Staff

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Bayer Campaign Aims to Make Saving Lives Something Common

Bayer Aspirin’s latest campaign, timed to American Heart Month, aims to raise awareness about heart attacks and about the role of aspirin in reducing the risk of complications.

The HeroSmith campaign began in February 2017 in Fort Smith, AR, a city with one of the highest rates of heart attacks in the country. Bayer Aspirin is encouraging all 1,800 city residents with the last name Smith to carry an aspirin with them at all times because if every Smith in Fort Smith carried aspirin, there could be a potential hero around every corner.

OCHWW Partners Form WPP Health & Wellness

Ogilvy CommonHealth Worldwide (OCHWW) has formed WPP Health & Wellness. Ogilvy operations in the United States will operate as one P&L under the leadership of newly appointed CEO Lou Aversano, previously CEO of Ogilvy & Mather New York.

Managing Partners Darlene Dobry and Shaun Urban explain the formation of the WPP Health & Wellness umbrella group will not change client relationships for its four agencies — Ogilvy CommonHealth Worldwide, ghg, Sudler & Hennessey, and CMI/Compas — but will enhance the agencies’ offerings by harnessing the power of WPP.

“WPP CEO Sir Martin Sorrell has spoken about his philosophy of horizontality for a number of years; horizontality being defined as reaching across, down, and within all of WPP to bring forward the best talent and resources to benefit our clients,” Mr. Urban says.

The agencies report directly to WPP Health & Wellness CEO Mike Hudnall, and retain their well-known brand identities. OCHWW CEO Matt Giegerich will retire after 25 years at the organization, and Ms. Dobry and Mr. Urban, along with partners Michael Parisi and Marc Weiner, are assuming his duties as an executive team. The partners report that Giegerich is leaving the healthcare agency business and moving on to new opportunities, and the transfer of responsibilities has already begun.

Annual Gala & Innovation Celebration

BioNJ’s 24th Annual Gateway Gala & Innovation Celebration, Feb. 2, 2017, brought together more than 700 attendees from biopharmaceutical companies, professional service providers, government officials, academic leaders and others for an evening of networking, business discussions, and award presentations.

This year, BioNJ presented the 10th Dr. Sol J. Barer Award for Vision, Innovation, and Leadership to Fred Hassan, partner and managing director, Warburg Pincus, and former chairman and CEO of Schering-Plough. As a globally recognized and revered biopharmaceutical leader, Mr. Hassan is widely regarded for his passion for patients, dedication to advancing healthcare, and mentoring industry leaders.

During his acceptance speech, Mr. Hassan lauded the industry for its dedication to innovation and patients.

Also during the evening, BioNJ presented its Innovator Awards honoring companies with a footprint in New Jersey that have received an FDA approval and industry leaders who have reached special milestones in 2016. In the drug approval category, awards were presented to: Allergan, Amicus Therapeutics, Bayer, Lilly, Elusys Therapeutics, Heron Therapeutics, Jazz Pharmaceuticals, Merck, Novo Nordisk, and Sanofi.

In the leadership category, BioNJ recognized: John Crowley, chairman and CEO, Amicus Therapeutics; Scott Jackson, former CEO, Celator Pharmaceuticals; Christian Kopfli, CEO, Chromocell; and Elizabeth Posillico, Ph.D., president and CEO, Elusys Therapeutics.

Policy champions Congressman Leonard Lance and Congressman Frank Pallone Jr. were honored.

Finally, BioNJ recognized patient advocates: Andrea, Natalie, and Hannah Gorsegner;● “Magic” Max Schill; and Don Wright — Marathon Man.(PV)



Cognizant Named a Digital Transformation Leader
Cognizant has been named by market intelligence and advisory services firm International Data Corporation a Digital Transformation Leader in the life-sciences industry. Cognizant was rated highly for project budget performance and for its experience in digital transformation throughout the supply chain, implementing IoT, smart manufacturing and monitoring, and smart analytics solutions that improve the quality, visibility, lead times and security of the supply chain.

Ogilvy CommonHealth Takes Home Two Graphis Annual award Recognitions
Ogilvy CommonHealth Worldwide, part of WPP Health & Wellness, has been awarded Gold and Silver honors at the Graphis Annual 2017 in the Print Pharmaceutical category.

The Graphis Annual recognizes the work of exceptional talent in Graphic Design, Advertising, Photography and Art/Illustration.

QuintilesIMS Honored
by Fortune
QuintilesIMS has been named to Fortune magazine’s World’s Most Admired Companies list. The 2017 listing marks the third year the company has been recognized. QuintilesIMS received the distinction in the “Healthcare: Pharmacy and Other Services” category with high marks in quality of management, value as a long-term investment, effectiveness in conducting business globally, and wise use of corporate assets.

Takeda Recognized as Sustainable Corporation
Takeda Pharmaceutical Company has been named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index. Takeda achieved this distinction for the second consecutive year and it is based on 14 key performance indicators, including energy productivity, innovation capacity, safety performance and leadership diversity.
Additionally, The Human Rights Campaign Foundation has named Takeda a best place to work for lesbian, gay, bisexual and transgender (LGBT) equality.  The company’s perfect score of 100 in the HRC’s 2017 Corporate Equality Index was earned on its first year of submitting an application for this award.

Posted in:

Post a Comment

You must be logged in to post a Comment.